| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.500 | None | 1.000 | 77 | 5 | 2002 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.961 | 76 | 0 | 2005 | 2019 | ||||||||
|
premelanosome protein | 0.531 | 0.769 | 3.1E-18 |
|
disease | 0.400 | None | 0.986 | 73 | 0 | 1994 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.986 | 70 | 12 | 1996 | 2020 | ||||||||
|
zinc fingers and homeoboxes 2 | 0.510 | 0.654 | 3.4E-02 |
|
disease | 0.100 | None | 1.000 | 67 | 0 | 2002 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 67 | 2 | 1989 | 2020 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 65 | 1 | 2003 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 1.000 | 61 | 0 | 1985 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.983 | 60 | 0 | 1999 | 2020 | ||||||||
|
RAB8A, member RAS oncogene family | 0.610 | 0.577 | 0.98 |
|
disease | 0.100 | None | 1.000 | 55 | 0 | 1993 | 2020 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
disease | 0.400 | None | 0.982 | 55 | 2 | 1996 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 0.981 | 53 | 0 | 1994 | 2019 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.100 | None | 0.961 | 51 | 0 | 1989 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 50 | 0 | 1991 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 0.980 | 49 | 1 | 2002 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.939 | 49 | 2 | 1994 | 2019 | ||||||||
|
melanoma cell adhesion molecule | 0.514 | 0.731 | 1.6E-04 |
|
disease | 0.100 | None | 0.959 | 49 | 0 | 1989 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.400 | None | 0.958 | 48 | 0 | 1984 | 2019 | |||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
disease | 0.100 | None | 0.938 | 48 | 0 | 1992 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.979 | 47 | 4 | 1991 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.700 | strong | 1.000 | 47 | 4 | 2001 | 2019 | ||||||||
|
dopachrome tautomerase | 0.619 | 0.654 | 7.4E-14 |
|
disease | 0.100 | None | 0.977 | 44 | 0 | 1994 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.700 | None | 1.000 | 44 | 15 | 2003 | 2019 | ||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.100 | None | 1.000 | 43 | 0 | 2005 | 2020 | |||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.953 | 43 | 0 | 1996 | 2018 |